The short answer
MOTS-c is supplied lyophilised and is most stable in that state, stored cold, dry and protected from light. Its two methionine residues oxidise readily, which is the principal degradation route. In solution stability falls substantially, and repeated freeze-thaw cycles should be avoided by aliquoting.
Key facts
- Supplied as
- White lyophilised powder
- Main degradation route
- Methionine oxidation (+16 Da per residue)
- Oxidation-prone residues
- Met1, Met6
- Disulfide risk
- None (no cysteine)
- Lyophilised storage
- Cold, dry, dark
- In solution
- Markedly less stable than lyophilised
- Freeze-thaw
- Avoid by aliquoting
Why the lyophilised form is stable
Freeze-drying removes water, and water is a participant in peptide-bond hydrolysis. A dry powder held cold has very limited routes to degrade. This is why peptides are shipped and stored lyophilised rather than in solution, and why the powder's condition on arrival matters. Material that has been through a warm transit has spent that time in a less protected state.
The specific vulnerability: methionine
MOTS-c has methionine at positions 1 and 6. The thioether sulfur in methionine oxidises to the sulfoxide readily in the presence of dissolved oxygen, and the reaction is accelerated by light and by temperature. Each oxidation adds 16 Da, so oxidised material appears as +16 and +32 satellites on a mass spectrum. This is the single most likely way a MOTS-c sample degrades, and it is why dark, cold, dry storage is not generic advice for this peptide but a specific response to its sequence.
Research material referenced
MOTS-C 10mg, third-party HPLC tested
What the absence of cysteine simplifies
With no cysteine there is no disulfide chemistry to manage. Peptides containing free thiols can dimerise or scramble intramolecular bonds, and often need reducing agents in buffer. None of that applies here, which makes MOTS-c handling simpler than its length would suggest.
Reconstitution
Bacteriostatic water (sterile water preserved with 0.9% benzyl alcohol) is the usual diluent for research peptides, because it permits repeated entry into the same vial over a limited window. Solvent should be introduced gently against the vial wall rather than directed onto the powder, and the vial swirled rather than shaken. Vigorous agitation generates an air-liquid interface, and peptides denature at that interface; foaming is a visible sign that it has happened.
Once in solution
Solution-phase material is subject to both hydrolysis and oxidation, and stability falls accordingly. Aliquoting into single-use volumes avoids repeated freeze-thaw cycling, which is independently damaging: each cycle concentrates solutes at the ice boundary and exposes the peptide to interfaces it does not tolerate well.
Signs of a problem
Visible particulates, cloudiness or discolouration in a reconstituted solution indicate something has gone wrong and the material should not be relied on for a measurement. A peptide that will not go into solution at a concentration it previously tolerated is also a signal, commonly of aggregation.
Frequently asked questions
Why is MOTS-c particularly sensitive to light and air?
Its two methionine residues oxidise to the sulfoxide in the presence of oxygen, and light and heat accelerate the reaction. Most 16-mers without methionine are less demanding.
Does MOTS-c need a reducing agent in buffer?
No. Reducing agents address disulfide chemistry, and MOTS-c has no cysteine.
Why avoid shaking the vial?
Shaking creates an air-liquid interface where peptides denature. Foam is the visible evidence. Swirl instead.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More MOTS-c (Mitochondrial Peptide) articles
- MOTS-c vs Humanin: How They DifferHumanin and MOTS-c are both mitochondrial-derived peptides but differ in gene of origin, length, receptor biology and research focus. A side-by-side comparison.
- MOTS-c in the Published LiteratureAround 250 indexed PubMed records on MOTS-c. The foundational papers, what kind of evidence exists, and how to read a largely preclinical literature accurately.
- Mitochondria Read DNA DifferentlyAUA means methionine in mitochondria and isoleucine everywhere else. A 2008 PNAS paper argues the deviation exists to raise methionine content.
- The Residue That Oxidises So Others Do NotMethionine oxidation is usually called damage. It is also reversible, which makes methionine a regenerable antioxidant buffer rather than a liability.
- Two Methionines in Sixteen ResiduesMOTS-c is 12.5% methionine against roughly 2.3% across proteins generally - a five-fold enrichment, in a peptide from the genome whose code favours it.